Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease.

  • Authors : Sadowska-Klasa A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.

Subjects: Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/prevention & control ; Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/virology ; Viral Load*

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1435-1439.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.

  • Authors : Chen HL; Department of Pediatrics, National Taiwan University College of Medicine and Children's Hospital, Taipei, Taiwan.; Department and Graduate Institute of Medical Education and Bioethics, National Taiwan University College of Medicine, Taipei, Taiwan.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives ; Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/prevention & control

  • Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Jun; Vol. 44 (6), pp. 1422-1434. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era.

  • Authors : Götz V; Faculty of Medicine, Division of Infectious Diseases, Department of Medicine II, Medical Center, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. .; Mathé P

Subjects: Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 923-933. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Early combination therapy of COVID-19 in high-risk patients.

  • Authors : Orth HM; Centre for Integrated Oncology (CIO), Aachen, Bonn, Cologne, Düsseldorf, (ABCD), Aachen, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19 Drug Treatment* ; Drug Therapy, Combination*

  • Source: Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 877-889. Date of Electronic Publication: 2023 Nov 29.Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis.

  • Authors : Elias KM; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.; Khan SR

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; COVID-19*/COVID-19*/COVID-19*/immunology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: The Lancet. Microbe [Lancet Microbe] 2024 May; Vol. 5 (5), pp. e459-e467. Date of Electronic Publication: 2024 Apr 04.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.

  • Authors : Wang Y; China-Japan Friendship Hospital, Beijing, China.; Hu H

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/therapy

  • Source: The New England journal of medicine [N Engl J Med] 2024 Apr 25; Vol. 390 (16), pp. 1534-1535.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2024 Apr 25; Vol. 390 (16), pp. 1534.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection.

  • Authors : Geng J; Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430200, China.; University of Chinese Academy of Sciences, Beijing 101408, China.

Subjects: Pyrazines*/Pyrazines*/Pyrazines*/therapeutic use ; Pyrazines*/Pyrazines*/Pyrazines*/pharmacology ; Amides*/Amides*/Amides*/pharmacology

  • Source: Viruses [Viruses] 2024 Apr 18; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

Evaluation of the Efficacy and Safety of Tenofovir Disoproxil Fumarate in Intercepting Mother-to-Child Transmission of Hepatitis B Virus.

  • Authors : Han D; Department of Obstetrics, Shijiazhuang Maternity & Child Healthcare Hospital.; Du J

Subjects: Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/Infectious Disease Transmission, Vertical*/prevention & control ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Hepatitis B*/Hepatitis B*/Hepatitis B*/transmission

  • Source: Acta medica Okayama [Acta Med Okayama] 2024 Apr; Vol. 78 (2), pp. 107-113.Publisher: Okayama University Medical School Country of Publication: Japan NLM ID: 0417611 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-world effectiveness of molnupiravir, azvudine and paxlovid against mortality and viral clearance among hospitalized patients with COVID-19 infection during the omicron wave in China: A retrospective cohort study.

  • Authors : Chen Y; Department of Infectious Diseases, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, PR China.; Lin Y

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19 Drug Treatment* ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

  • Source: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Aug; Vol. 109 (4), pp. 116353. Date of Electronic Publication: 2024 May 18.Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  5,611 results for ""VIRAL load""